Clinical evidence on PET–CT for radiation therapy planning in cervix and endometrial cancers
- 1 September 2010
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 96 (3) , 351-355
- https://doi.org/10.1016/j.radonc.2010.07.010
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- FDG for dose painting: A rational choiceRadiotherapy and Oncology, 2010
- Image-guided brachytherapy sets benchmarks in advanced radiotherapyRadiotherapy and Oncology, 2009
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometriumInternational Journal of Gynecology & Obstetrics, 2009
- Positron-emission tomography in gynaecologic malignanciesArchiv für Gynäkologie, 2009
- New trends in the evaluation and treatment of cervix cancer: The role of FDG–PETCancer Treatment Reviews, 2008
- FDG-PET in gynaecological cancers: recent observationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- The diagnostic value of PET/CT scanning in patients with cervical cancer: A prospective studyGynecologic Oncology, 2007
- Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancerMolecular Imaging & Biology, 2004
- Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.Radiology, 1998
- Radiological Evaluation of Lymph Node Metastases in Patients With Cervical CancerJAMA, 1997